Crossref
Hormone therapy in younger women: reassessing risk narratives in the era of precision menopausal care
Chinese Clinical Oncology · 2026-04 · 15 (2) · 25-25
DOI: 10.21037/cco-2025-1-166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Clinical Oncology, 2026-04. Verfasst von Auro Del Giglio. Beteiligte Einrichtung: Department of Oncology and Hematology, Centro Universitário FMABC, São Bernardo do Campo, São Paulo, Brazil.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Young-onset breast cancerestrogenestrogen plus progestinhormone therapy (HT)perimenopause
Autor:innen und Institutionen
- Department of Oncology and Hematology, Centro Universitário FMABC, São Bernardo do Campo, São Paulo, Brazil.
Zitieren
APA
Del Giglio, A. (2026). Hormone therapy in younger women: reassessing risk narratives in the era of precision menopausal care. Chinese Clinical Oncology, 15(2), 25-25. https://doi.org/10.21037/cco-2025-1-166
Vancouver
Del Giglio A. Hormone therapy in younger women: reassessing risk narratives in the era of precision menopausal care. Chinese Clinical Oncology. 2026;15(2):25-25. doi:10.21037/cco-2025-1-166
BibTeX
@article{DelGiglio2026,
author = {Del Giglio, Auro},
title = {Hormone therapy in younger women: reassessing risk narratives in the era of precision menopausal care},
journal = {Chinese Clinical Oncology},
year = {2026},
volume = {15},
number = {2},
pages = {25--25},
doi = {10.21037/cco-2025-1-166}
}
EUVIMED